Edible Garden exchanges $135k Series B Preferred for 128,119 common shares in two deals

Edible Garden AG Inc

On March 26 and April 15, 2026, exchanged 75 and 60 Series B Preferred shares (total stated value $135,000) for 128,119 common shares with Streeterville Capital.
Exchange price based on Nasdaq Minimum Price day before each agreement; issued under Section 3(a)(9) exemption from registration.
Issuance was unregistered, no underwriter; shares are restricted.
Transaction reduces preferred stock outstanding and increases common share count by 128,119.

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

Edible Garden AG Inc issued 128,119 shares of common stock of common stock to Streeterville Capital, LLC for exchange of 75 and 60 shares of Series B Preferred Stock with aggregate stated value of $135,000.

Security: common stock
Shares: 128,119 shares of common stock
Purchaser: Streeterville Capital, LLC
Consideration: exchange of 75 and 60 shares of Series B Preferred Stock with aggregate stated value of $135,000

Exact text from the filing

On March 26, 2026 and April 15, 2026, Edible Garden AG Incorporated (the “Company”) entered into exchange agreements (the “Exchange Agreements”) with Streeterville Capital, LLC, a Utah limited liability company (“Streeterville”) pursuant to which the Company agreed to exchange 75 and 60 shares, respectively, of the Company’s Series B Preferred Stock, par value $0.0001 per share (the “Preferred Stock”), for a total of 128,119 shares of the Company’s common stock, par value $0.0001 per share (“Exchange Shares”).

View on SEC.gov

Browse all equity issuances →

Edible Garden AG Inc filing history →

Source: SEC EDGAR

accession 0001477932-26-002447

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.